2023
DOI: 10.1016/j.mam.2023.101219
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic strategies for glaucoma and optic neuropathies

Jung Lo,
Kamakshi Mehta,
Armaan Dhillon
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 174 publications
0
1
0
Order By: Relevance
“…However, it is important to note that not all the individuals with a high IOP develop glaucoma, and, conversely, glaucoma can occur in those with a normal IOP, suggesting that other factors play a crucial role [365]. However, existing treatment paradigms focus on reducing the intraocular pressure, mainly through the daily use of eye drops, sometimes associated with side effects or invasive surgical interventions [366,367]. The frequent inadequacy of ocular pressure-lowering approaches, substantial rates of treatment non-adherence affecting 30-70% of patients, and resulting financial burdens indicate the need for long-lasting, neuroprotective therapies.…”
Section: Glaucomamentioning
confidence: 99%
“…However, it is important to note that not all the individuals with a high IOP develop glaucoma, and, conversely, glaucoma can occur in those with a normal IOP, suggesting that other factors play a crucial role [365]. However, existing treatment paradigms focus on reducing the intraocular pressure, mainly through the daily use of eye drops, sometimes associated with side effects or invasive surgical interventions [366,367]. The frequent inadequacy of ocular pressure-lowering approaches, substantial rates of treatment non-adherence affecting 30-70% of patients, and resulting financial burdens indicate the need for long-lasting, neuroprotective therapies.…”
Section: Glaucomamentioning
confidence: 99%